Future Oncology Journal Issues Research Articles in Vol. 19, No. 16
July 10, 2023
July 10, 2023
LONDON, England, July 10 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 19, No. 16 edition:
Plain Language Summary of Publication:
* COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF
Drug Evaluation:
* Margetuximab in HER2-positive met . . .
Plain Language Summary of Publication:
* COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF
Drug Evaluation:
* Margetuximab in HER2-positive met . . .